Experience with 4′-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosis
Authors:
- R.W. SonntagRSR.W. Sonntag
- H.J. SennHSH.J. Senn
- G. NagelGNG. Nagel
- K. GigerKGK. Giger
- P. AlbertoPAP. Alberto
- 28 February 1974
- journal article
- Published by Elsevier in European Journal of Cancer (1965)
- Vol. 10 (2) , 93-98
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Clinical Screening of Epipodophyllotoxin VM26 in Malignant Lymphomas and Solid TumoursBMJ, 1972
- 4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of actionEuropean Journal of Cancer (1965), 1970
- Therapie karzinomatöser Endstadien mit SP-G und SP-I1DMW - Deutsche Medizinische Wochenschrift, 1964